Publications by authors named "Inbar Levi"

Claim this Profile
H
Humoral and Cellular Immune Responses of People Living With Human Immunodeficiency Virus After 3 Doses of Messenger RNA BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine: A Prospective Cohort Study.
Luba Tau, David Hagin, Tal Freund, Tamar Halperin, Amos Adler, Inbar Levi

Open Forum Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical Center.
Luba Tau, Dan Turner, Amos Adler, Rotem Marom, Svetlana Ahsanov, Inbar Levi

Open Forum Infect Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity.
David Hagin, Tal Freund, Michal Navon, Tami Halperin, Dikla Adir, Inbar Levi

J Allergy Clin Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity.
Vered Daitch, Mical Paul, George L Daikos, Emanuele Durante-Mangoni, Dafna Yahav, Inbar Levi

BMC Infect Dis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
Mical Paul, George L Daikos, Emanuele Durante-Mangoni, Dafna Yahav, Yehuda Carmeli, Inbar Levi

Lancet Infect Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence variation in results in a novel form of cardio-cutaneous syndrome.
Tzipora C Falik-Zaccai, Yiftah Barsheshet, Hanna Mandel, Meital Segev, Avraham Lorber, Inbar Levi

EMBO Mol Med· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence variation in results in a novel form of cardio-cutaneous syndrome.
Tzipora C Falik-Zaccai, Yiftah Barsheshet, Hanna Mandel, Meital Segev, Avraham Lorber, Inbar Levi

EMBO Mol Med· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
Yaakov Dickstein, Leonard Leibovici, Dafna Yahav, Noa Eliakim-Raz, George L Daikos, Inbar Levi

BMJ Open· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of tumor infiltrating natural killer cell subset.
Inbar Levi, Hagai Amsalem, Aviram Nissan, Merav Darash-Yahana, Tamar Peretz

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cells exposed to sublethal oxidative stress selectively attract monocytes/macrophages via scavenger receptors and MyD88-mediated signaling.
Anat Geiger-Maor, Inbar Levi, Sharona Even-Ram, Yoav Smith, Dawn M Bowdish

J Immunol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis